Strategic Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Strategic Wealth Management Group's PFE Position: Q2 2021 in Review
Strategic Wealth Management Group reduced its Pfizer (PFE) stake by 34% in Q2 2021, selling an estimated $125K and leaving 6,314 shares worth $247K. The position accounts for 0.09% of the portfolio, ranked #109.
Strategic Wealth Management Group first reported a position in PFE in Q4 2018 and has held it in 10 quarters since. The position peaked at $345K in Q1 2021. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Strategic Wealth Management Group held 6,314 shares of Pfizer worth $247K as of Q2 2021.
- Strategic Wealth Management Group sold 3,218 Pfizer shares in Q2 2021, an estimated $125K.
- Pfizer made up 0.09% of Strategic Wealth Management Group's portfolio in Q2 2021, its #109 holding.
- Strategic Wealth Management Group first reported a position in Pfizer in Q4 2018 and has held it in 10 quarters since.
- Strategic Wealth Management Group's Pfizer position peaked at $345K in Q1 2021.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.